1999
DOI: 10.1016/s0014-2999(99)00410-0
|View full text |Cite
|
Sign up to set email alerts
|

κ-Opioid receptor antisense oligonucleotide injected into rat hippocampus causes hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2000
2000
2007
2007

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 19 publications
0
6
0
Order By: Relevance
“…Antisense ODNs targeting the KOR have been shown to selectively inhibit -ORA antinociception in rats (Adams et al, 1994) and, more recently, to cause hypertension after injection into the hippocampus (Wright et al, 1999). Intrathecal administration of antisense ODNs has also been demonstrated to cause a knockdown of peripheral proteins.…”
Section: Antisense Strategies In Opioid Pharmacologymentioning
confidence: 99%
“…Antisense ODNs targeting the KOR have been shown to selectively inhibit -ORA antinociception in rats (Adams et al, 1994) and, more recently, to cause hypertension after injection into the hippocampus (Wright et al, 1999). Intrathecal administration of antisense ODNs has also been demonstrated to cause a knockdown of peripheral proteins.…”
Section: Antisense Strategies In Opioid Pharmacologymentioning
confidence: 99%
“…Fluctuations in circulating adrenal steroids during stress represent another important influence on prepro‐NPY mRNA expression in the hippocampus, particularly in the dentate gyrus (17, 57). Furthermore, the hippocampus has been implicated in learning and memory (14, 58), behaviour and emotion (59) and cardiovascular control (60), suggesting that these functions may be influenced by differences in the NPY response to restraint at the level of the hippocampus and dentate gyrus in SHR.…”
Section: Discussionmentioning
confidence: 99%
“…Destruction of the dynorphin-producing cells of the dentate gyrus by colchicine induces hypertension in the WKY rat and accelerates its development in SHR (12). More recently we were able to show that an antisense oligonucleotide directed against the kappa receptor, when microinjected bilaterally into the hippocampus, induced hypertension in WKY rats and increased arterial blood pressure in SHR (13). Furthermore, we have shown that microinfusions of both dynorphins and non-peptide kappa agonists into rat hippocampus lower MAP and HR in both SHR and WKY (more so in SHR) (14,15).…”
Section: Introductionmentioning
confidence: 93%